Work

Abstract PS5-02-07: Her2-overexpressing circulating tumor cells in patients treated by trastuzumab deruxtecan for metastatic her2+ breast cancer: clinical and prognostic implications

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-02-07

Authors: W. Jacot, F. Bidard, R. Colin-Chevalier, S. Guiu, S. Renault, G. Lossaint, J. Pierga, L. Cayrefourcq, F. Fiteni, C. Alix-Panabières

Institutions: Institut Curie, Inserm, Institut de Recherche en Cancérologie de Montpellier, Université de Montpellier, Université de Nîmes

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129449654

Cites:

Cited by:

Related to: